Nichol Ochsner | Vice President of Investor Relations |
Robert Finizio | Chief Executive Officer |
James D’Arecca | Chief Financial Officer |
Dawn Halkuff | Chief Commercial Officer |
Mitch Krassan | Chief Strategy and Performance Officer |
Jen Kim | Cantor Fitzgerald |
Stacy Ku | Cowen and Company |
Douglas Tsao | H.C. Wainwright |
Annabel Samimy | Stifel Financial Corp. |
Good morning, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD second quarter 2020 financial results conference call. [Operator Instructions] I would now like to turn the call over to TherapeuticsMD’s vice president of investor relations, Nichol Ochsner. Nichol, you may begin.
Good morning, everyone.